Table 1 Baseline characteristics of patients who underwent carotid artery stenting with different filter-based embolic protection devices
From: Treatment outcomes of carotid artery stenting with two types of distal protection filter device
FilterWire1(n = 121) | Spider2(n = 37) | p-value | |
|---|---|---|---|
Age, sex | |||
Mean age (years) | 72.6 ± 9.0 | 71.1 ± 8.6 | 0.39* |
Male | 104 (84%) | 29 (78%) | 0.26** |
Cardiovascular risk factor | |||
Diabetes mellitus | 38 (31%) | 13 (37%) | 0.67** |
Hypertension | 96 (79%) | 29 (78%) | 0.89** |
Dyslipidemia | 58 (48%) | 20 (54%) | 0.51** |
Atrial fibrillation | 15 (11%) | 4 (11%) | 0.79** |
History of cardiovascular disease | 22 (18%) | 6 (16%) | 0.78** |
Presenting symptom | |||
Cerebral infarction | 53 (43%) | 18 (48%) | 0.60** |
TIA3 or amaurosis fugax | 11 (9.1%) | 4 (11%) | 0.75** |
Asymptomatic | 57 (47%) | 15 (41%) | 0.48** |
Degree of carotid artery stenosis | 77.5 ± 13.1 | 75.2 ± 14.6 | 0.39* |